Axon Enterprise (AXON) CLO Isaiah Fields reports 57,588.31 shares held

Rhea-AI Filing Summary

Axon Enterprise, Inc. reported the initial holdings of Chief Legal Officer Isaiah Fields as of January 1, 2026 on a Form 3. He beneficially owned 57,588.31 shares of common stock, held directly.

This amount includes 16,001.31 restricted stock units from four time-vested awards under the Axon Amended and Restated 2022 Stock Incentive Plan, scheduled to vest in tranches from March 3, 2026 through November 30, 2028. It also includes 10,488 performance-based restricted stock units granted for achievement of tranche 3 of the 2024 eXponential Stock Plan, which are set to vest on June 1, 2026, followed by a minimum holding period until the earlier of December 31, 2030 or a subsequent tranche vesting. In addition, the total reflects 31,099 shares previously issued upon the release of time- and performance-based RSUs prior to January 1, 2026.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Fields Isaiah

(Last) (First) (Middle)

17800 N 85TH ST

(Street)

SCOTTSDALE AZ 85255

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/01/2026

3. Issuer Name and Ticker or Trading Symbol
AXON ENTERPRISE, INC. [ AXON ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	57,588.31	D(1)(2)(3)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 16,001.31 restricted stock units subject to vesting conditions related to four separate time-vested awards granted to the reporting person pursuant to the Axon Enterprise, Inc. Amended and Restated 2022 Stock Incentive Plan. The grants will vest 1,782 shares on March 3, 2026, 1,781 shares on each of May 31, 2026, August 31, 2026, and November 30, 2026, 1,238 shares on each of March 3, 2027, May 31, 2027, August 31, 2027, and November 30, 2027, 981.08 shares on each of March 3, 2028, May 31, 2028, and August 31, 2028, and 981.07 shares on November 30, 2028.

2. Includes 10,488 performance-based restricted stock units granted on December 22, 2023, for the achievement of tranche 3 of the Axon Enterprise, Inc. 2024 eXponential Stock Plan, for which the performance conditions were certified by the Compensation Committee on November 13, 2025 as having been met. The restricted stock units will vest on June 1, 2026, subject to continued employment through such date. Following the vesting, the shares are subject to a minimum holding period from the vesting date until the earlier of (i) December 31, 2030 and (ii) the date that a subsequent tranche vests, excluding shares that are withheld or sold to cover taxes.

3. Includes 31,099 shares issued upon the release of time-vested restricted stock units and performance-based restricted stock units prior to January 1, 2026

Remarks:

	Isaiah Fields	01/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does Axon (AXON) disclose in this Form 3 for Isaiah Fields?

The filing reports that Chief Legal Officer Isaiah Fields beneficially owned 57,588.31 shares of Axon common stock directly as of January 1, 2026.

How many Axon shares does Isaiah Fields beneficially own according to this filing?

He beneficially owns 57,588.31 shares of Axon common stock, including time-vested and performance-based restricted stock units and previously released RSUs.

What time-vested restricted stock units are included in Isaiah Fields’ Axon holdings?

His holdings include 16,001.31 restricted stock units from four time-vested awards under the Axon Amended and Restated 2022 Stock Incentive Plan, vesting in scheduled tranches between March 3, 2026 and November 30, 2028.

What performance-based RSUs are reported for Isaiah Fields at Axon (AXON)?

The filing includes 10,488 performance-based restricted stock units granted on December 22, 2023 for achievement of tranche 3 of Axon’s 2024 eXponential Stock Plan, with vesting on June 1, 2026, subject to continued employment.

Is there a holding period on Isaiah Fields’ performance-based Axon RSUs after vesting?

Yes. After vesting on June 1, 2026, the resulting shares are subject to a minimum holding period until the earlier of December 31, 2030 or the date a subsequent tranche vests, excluding shares withheld or sold to cover taxes.

What portion of Isaiah Fields’ Axon holdings comes from previously released RSUs?

His total includes 31,099 shares issued upon the release of time-vested and performance-based restricted stock units prior to January 1, 2026.

Is the ownership reported by Isaiah Fields in Axon stock direct or indirect?

The 57,588.31 shares of common stock are reported as held directly (D), with no separate entity or indirect ownership structure disclosed in this excerpt.